Use of multicellular tumor spheroids to dissect endothelial cell–tumor cell interactions: A role for T‐cadherin in tumor angiogenesis

[1]  David G. Wilkinson,et al.  T-cadherin suppresses angiogenesis in vivo by inhibiting migration of endothelial cells , 2007, Angiogenesis.

[2]  L. Terracciano,et al.  Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytes , 2007, British Journal of Cancer.

[3]  D. Piatier‐Tonneau,et al.  Expression of T‐cadherin in tumor cells influences invasive potential of human hepatocellular carcinoma , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  P. Erne,et al.  Atypical GPI-Anchored T-Cadherin Stimulates Angiogenesis In Vitro and In Vivo , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[5]  Weibo Cai,et al.  Anti-Angiogenic Cancer Therapy Based on Integrin αvβ3 Antagonism , 2006 .

[6]  Ya-jun Guo,et al.  Concordant loss of melanoma differentiation antigens in synchronous and asynchronous melanoma metastases: implications for immunotherapy , 2006, Melanoma research.

[7]  G. Alghisi,et al.  Vascular integrins in tumor angiogenesis: mediators and therapeutic targets. , 2006, Endothelium : journal of endothelial cell research.

[8]  G. Tucker.  Integrins: Molecular targets in cancer therapy , 2006, Current oncology reports.

[9]  W. Cai,et al.  Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism. , 2006, Anti-cancer agents in medicinal chemistry.

[10]  Y. Ohtsuki,et al.  An adiponectin receptor, T-cadherin, was selectively expressed in intratumoral capillary endothelial cells in hepatocellular carcinoma: possible cross talk between T-cadherin and FGF-2 pathways , 2006, Virchows Archiv.

[11]  Michael Heberer,et al.  Culture of Melanoma Cells in 3-Dimensional Architectures Results in Impaired Immunorecognition by Cytotoxic T Lymphocytes Specific for Melan-A/MART-1 Tumor-Associated Antigen , 2005 .

[12]  R. Rosenthal,et al.  Culture of melanoma cells in 3-dimensional architectures results in impaired immunorecognition by cytotoxic T lymphocytes specific for Melan-A/MART-1 tumor-associated antigen. , 2005, Annals of surgery.

[13]  Manish Gala,et al.  Induction of interleukin-8 preserves the angiogenic response in HIF-1α–deficient colon cancer cells , 2005, Nature Medicine.

[14]  Ivan Martin,et al.  Three‐dimensional culture of melanoma cells profoundly affects gene expression profile: A high density oligonucleotide array study , 2005, Journal of cellular physiology.

[15]  P. Erne,et al.  RhoA and Rac mediate endothelial cell polarization and detachment induced by T‐cadherin , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  G. Parmiani,et al.  A listing of human tumor antigens recognized by T cells: March 2004 update , 2005, Cancer Immunology, Immunotherapy.

[17]  M. Kreuter,et al.  Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. , 2004, The Journal of clinical investigation.

[18]  P. Erne,et al.  T-cadherin upregulation correlates with cell-cycle progression and promotes proliferation of vascular cells. , 2004, Cardiovascular research.

[19]  M. Rosenkilde,et al.  The chemokine system – a major regulator of angiogenesis in health and disease , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[20]  P. Erne,et al.  Cell adhesion molecule T-cadherin regulates vascular cell adhesion, phenotype and motility. , 2004, Experimental cell research.

[21]  E. Padovan,et al.  Phase I/II clinical trial of a nonreplicative vaccinia virus expressing multiple HLA-A0201-restricted tumor-associated epitopes and costimulatory molecules in metastatic melanoma patients. , 2003, Human gene therapy.

[22]  Pierre Corvol,et al.  Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. , 2003, The American journal of pathology.

[23]  Michelle L. Varney,et al.  IL-8 Directly Enhanced Endothelial Cell Survival, Proliferation, and Matrix Metalloproteinases Production and Regulated Angiogenesis1 , 2003, The Journal of Immunology.

[24]  B. Mian,et al.  Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. , 2002, The American journal of pathology.

[25]  R. Jain,et al.  Acidic Extracellular pH Induces Vascular Endothelial Growth Factor (VEGF) in Human Glioblastoma Cells via ERK1/2 MAPK Signaling Pathway , 2002, The Journal of Biological Chemistry.

[26]  E. Padovan,et al.  Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivo. , 2002, Human gene therapy.

[27]  Rolf M. Zinkernagel,et al.  Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction , 2001, Nature.

[28]  P. Robbins,et al.  A listing of human tumor antigens recognized by T cells , 2001, Cancer Immunology, Immunotherapy.

[29]  O. Oudar.  Spheroids: relation between tumour and endothelial cells. , 2000, Critical reviews in oncology/hematology.

[30]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[31]  R. Klemenz,et al.  Advances in Brief Increased Expression of H/T-Cadherin in Tumor-penetrating Blood Vessels 1 , 2022 .

[32]  W. Mueller‐Klieser.  Three-dimensional cell cultures: from molecular mechanisms to clinical applications. , 1997, American journal of physiology. Cell physiology.

[33]  W. Mueller‐Klieser.  Three-dimensional cell cultures: from molecular mechanisms to clinical applications. , 1997, American journal of physiology. Cell physiology.

[34]  B. Fredette,et al.  Inhibition of motor axon growth by T-cadherin substrata. , 1996, Development.

[35]  F. Jotereau,et al.  Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions , 1996, The Journal of experimental medicine.

[36]  R. Strieter,et al.  Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.

[37]  C. Kirkpatrick,et al.  Interaction of human malignant melanoma (ST-ML-12) tumor spheroids with endothelial cell monolayers. Damage to endothelium by oxygen-derived free radicals. , 1992, The American journal of pathology.

[38]  D. Ruiter,et al.  Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. , 1991, The American journal of pathology.

[39]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.